NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ROTH Capital Partners (ROTH), www.roth.com, a full-service investment bank focused on serving emerging growth companies and their investors, today announced that it will host its Healthcare Corporate Access Day on Tuesday, June 24, 2014, at the Dorchester Hotel in London, U.K.
ROTH’s Healthcare Corporate Access Day will give investors the opportunity to interact with senior management of a select group of Life Sciences companies focused in the Biotechnology and Specialty Pharmaceuticals sectors.
The event will allow for extensive interaction and one-on-one meetings with management teams, providing in-depth insights into each company.
ROTH biotechnology senior research analysts Joe Pantginis, Ph.D., Ed Arce and Debjit Chattopadhyay, Ph.D., as well as Specialty Pharmaceuticals senior research analyst Scott Henry, CFA, will be available to discuss their perspectives regarding the companies attending and their views regarding the current healthcare market trends.
“The Life Sciences sector has been highly visible in the pace of clinical milestones and advancements achieved as well as the record levels of capital markets activity over the last several years. Given the rapid developments and changing dynamics in this sector, our objective of this corporate access day is to provide investors with direct interactions with management teams of a select group of high quality companies from early to late stage development, through commercialization,” commented John W. Chambers, Managing Director and Head of Healthcare Investment Banking at ROTH. “These companies, representing a broad range of market capitalizations, will enable investors to further understand their scientific approach, clinical achievements to date and upcoming milestones and catalysts. This event comprising exclusively one-on-one meetings will enable investors to gain direct insight into the key value drivers for this group of innovative companies.”
ROTH has built a leading Healthcare Investment Banking Group over the last several years and has raised approximately $7 billion in over 200 Healthcare transactions since 2010. *Past Performance is not indicative of future returns. (Source: ROTH Capital 06/05/2014)
The event is for institutional clients of ROTH and is by invitation only. For more information, please contact your ROTH sales representative at 949-720-5700 or e-mail: conference@roth.com.
Agenda and Events
Monday | June 23, 2014
5:00 pm - 7:00 pm | Cocktail Reception
Tuesday | June 24, 2014
8:00 am - 9:00 am | Morning Coffee
12:00
pm - 1:00 pm | Lunch
9:00 am - 5:00 pm | 1-on-1 / Small Group
Meetings
Venue:
The Dorchester
3 Tilney Street
London, W1K
1BJ, UK
Tel: +44 (0) 20-7629-8888
Participating Companies
The following participating
companies are confirmed as of the date of this release:
AcelRx Pharmaceuticals, Inc. (ACRX)
BioLineRx, Ltd. (BLRX)
Can-Fite
BioPharma Ltd. (CANF)
CTI Biopharma (CTIC)
Curis, Inc. (CRIS)
Derma
Sciences Inc. (DSCI)
Durata Therapeutics, Inc. (DRTX)
Galena
Biopharma, Inc. (GALE)
IntelliPharmaCeutics International Inc.
(IPCI)
Lannett Company, Inc. (LCI)
Ligand Pharmaceuticals
Incorporated (LGND)
NeoGenomics (NEO)
Newron Pharmaceuticals
S.p.A. (SWX:NWRN)
Pharming Group NV (PHARM)
Prosensa Holding
NV (RNA)
Prothena Corporation (PRTA)
PTC Therapeutics, Inc.
(PTCT)
RedHill Biopharma (RDHL)
Rexahn Pharmaceuticals, Inc.
(RNN)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Verastem,
Inc. (VSTM)
Event sponsors include Business Wire and Equisolve.
About Roth Capital Partners, LLC:
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately held and employee owned, and maintains offices throughout the U.S. and Hong Kong. For more information on ROTH, please visit www.roth.com.
